+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07619287

Study of BG-75202 Alone and with Other Agents to Assess Safety and Early Effects in Adults with Myeloid Malignancies

Led by BeOne Medicines · Updated on 2026-09-28

118

Participants Needed

17

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying BG-75202, a KAT6AB inhibitor, alone and combined with other agents to assess its safety, tolerability, pharmacokinetics, pharmacodynamics, and early effectiveness in adults with myeloid malignancies. This Phase 1a1b trial focuses on patients with relapsed or refractory myeloid cancers who have received prior treatments. The study aims to identify appropriate dosing and evaluate treatment responses according to established criteria. Participants will receive BG-75202 as monotherapy or in combination with a hypomethylation agent HMA. The study follows sequential cohorts with increasing doses to determine safe and effective doses. BG-75202 is given orally, while the HMA is administered intravenously or subcutaneously. The trial includes dose escalation and dose optimization phases to find the recommended doses for expansion and further study. Throughout the trial, participants will be closely monitored for adverse events and treatment responses for up to 18 months. Researchers will collect pharmacokinetic data, including drug concentration in plasma over time, and measure clinical outcomes such as complete remission rates and survival. Safety assessments continue for 30 days after the last dose or until new anticancer therapy starts. Participants health and blood work will be regularly evaluated to track the effects of the study drugs.

CONDITIONS

Brief Title

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies

Research Team

S

Study Director

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here